Ligand supplementation restores the cancer therapy efficacy of the antirheumatic drug auranofin from serum inactivation

Yuan Wang, Bei Cao, Qianqian Wang, Sinan Zhong, Xin Fang, Junjian Wang (), Albert S. C. Chan, Xiaolin Xiong () and Taotao Zou ()
Additional contact information
Yuan Wang: Sun Yat-Sen University
Bei Cao: The Hong Kong University of Science and Technology (Guangzhou)
Qianqian Wang: Sun Yat-Sen University
Sinan Zhong: Sun Yat-Sen University
Xin Fang: Sun Yat-Sen University
Junjian Wang: Sun Yat-Sen University
Albert S. C. Chan: Sun Yat-Sen University
Xiaolin Xiong: Sun Yat-Sen University
Taotao Zou: Sun Yat-Sen University

Nature Communications, 2025, vol. 16, issue 1, 1-13

Abstract: Abstract Auranofin, an FDA-approved antirheumatic gold drug, has gained ongoing interest in clinical studies for treating advanced or recurrent tumors. However, gold ion’s dynamic thiol exchange nature strongly attenuates its bioactivity due to the fast formation of covalent albumin-gold adducts. Here we report that newly-added thiols can modulate the dynamic albumin-gold binding and recover the therapeutic efficacy. Initially, we find that auranofin supplemented with its own thiol ligand, TGTA (1-thio-β-D-glucose tetraacetate), significantly restores the anticancer activities in cells and patient-derived xenograft models. Then, screening a collection of ligand fragments followed by machine learning evaluation unveils diverse synergizing thiols, including pantethine, that effectuate auranofin at a low dosage for rheumatoid arthritis. Interestingly, the thiol exchange inside cells accounts for a cuproptosis-like phenotype that auranofin induces. Together, we believe the ligand-enabled dynamic modulation strategy is of value to researchers and clinicians contemplating metallodrugs and ligand-like molecules in cancer therapy.

Date: 2025
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-025-62634-9 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62634-9

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-025-62634-9

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().